PPARA, peroxisome proliferator activated receptor alpha, 5465
N. diseases: 408; N. variants: 20
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
22 | 46231706 | intron variant | C/T | snv | 7.8E-02 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
22 | 46231706 | intron variant | C/T | snv | 7.8E-02 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
22 | 46155064 | non coding transcript exon variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
22 | 46155064 | non coding transcript exon variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
22 | 46167520 | intron variant | A/G | snv | 7.1E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
22 | 46167520 | intron variant | A/G | snv | 7.1E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
22 | 46167520 | intron variant | A/G | snv | 7.1E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
22 | 46167520 | intron variant | A/G | snv | 7.1E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
22 | 46167520 | intron variant | A/G | snv | 7.1E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
22 | 46219479 | intron variant | G/A | snv | 8.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
22 | 46219479 | intron variant | G/A | snv | 8.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
22 | 46231706 | intron variant | C/T | snv | 7.8E-02 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.080 | 22 | 46241357 | 3 prime UTR variant | G/A | snv | 0.19 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.641 | 0.640 | 22 | 46218377 | missense variant | C/G | snv | 4.3E-02 | 4.2E-02 |
|
0.700 | 0 | ||||||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.100 | 0.762 | 21 | 1997 | 2018 | |||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.100 | 0.769 | 13 | 1997 | 2018 | |||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Endocrine System Diseases | 0.070 | 0.571 | 7 | 2001 | 2012 | |||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.070 | 0.571 | 7 | 2001 | 2012 | |||||||
|
0.641 | 0.640 | 22 | 46218377 | missense variant | C/G | snv | 4.3E-02 | 4.2E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.070 | 0.857 | 7 | 2000 | 2013 | ||||||
|
0.641 | 0.640 | 22 | 46218377 | missense variant | C/G | snv | 4.3E-02 | 4.2E-02 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.060 | 0.667 | 6 | 2001 | 2016 | ||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.040 | 0.750 | 4 | 2010 | 2012 | |||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Nutritional and Metabolic Diseases | 0.040 | 1.000 | 4 | 2001 | 2012 | |||||||
|
0.641 | 0.640 | 22 | 46218377 | missense variant | C/G | snv | 4.3E-02 | 4.2E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.040 | 0.750 | 4 | 2005 | 2007 | ||||||
|
0.637 | 0.600 | 22 | 46198429 | missense variant | G/C;T | snv | 4.0E-06; 4.0E-06 |
|
Nutritional and Metabolic Diseases | 0.030 | 1.000 | 3 | 2002 | 2012 | |||||||
|
0.641 | 0.640 | 22 | 46218377 | missense variant | C/G | snv | 4.3E-02 | 4.2E-02 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2004 | 2016 |